유나이티드 테라퓨틱스 (UTHR)

08:10 AM

United Therapeutics (UTHR) Receives Reiterated "Buy" Rating from HC Wainwright | UTHR Stock News - GuruFocus

08:10 AM

May 02, 2025

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia - GlobeNewswire Inc.

May 02, 2025

May 02, 2025

United Therapeutics (UTHR) Gets a Hold from Wells Fargo - The Globe and Mail

May 02, 2025

May 01, 2025

BofA raises United Therapeutics stock target to $321 - Investing.com Australia

May 01, 2025

May 01, 2025

United Therapeutics (UTHR): Morgan Stanley Raises Price Target | - GuruFocus

May 01, 2025

May 01, 2025

BofA raises United Therapeutics stock target to $321 By Investing.com - Investing.com Canada

May 01, 2025

May 01, 2025

United Therapeutics (UTHR) Analyst Update: JP Morgan Maintains R - GuruFocus

May 01, 2025

May 01, 2025

United Therapeutics (UTHR) Analyst Update: JP Morgan Maintains Rating | UTHR Stock News - GuruFocus

May 01, 2025

May 01, 2025

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus

May 01, 2025

May 01, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q1 2025 Earnings Call Transcript - Insider Monkey

May 01, 2025

May 01, 2025

United Therapeutics: Q1 Earnings Snapshot - New Haven Register

May 01, 2025

May 01, 2025

United Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance

May 01, 2025

May 01, 2025

United Therapeutics Reports Strong Q1 2025 Growth - TipRanks

May 01, 2025

Apr 30, 2025

United Therapeutics Corp. Reports Record Revenue Growth - TipRanks

Apr 30, 2025

Apr 30, 2025

Earnings call transcript: United Therapeutics Q1 2025 beats expectations - Investing.com

Apr 30, 2025

Apr 30, 2025

United Therapeutics Corp Surpasses Q1 2025 Estimates with $7.18 EPS and $794.4 Million Revenue - GuruFocus

Apr 30, 2025

Apr 30, 2025

United Therapeutics (UTHR) Surpasses Q1 Earnings Expectations - GuruFocus

Apr 30, 2025

Apr 30, 2025

United Therapeutics beats Q1 estimates, shares edge higher - Investing.com

Apr 30, 2025

Apr 30, 2025

United Therapeutics Q1 Earnings, Revenue Rise - marketscreener.com

Apr 30, 2025

Apr 30, 2025

United Therapeutics Q1 2025 slides: revenue jumps 17%, organ transplant milestone nears - Investing.com

Apr 30, 2025

Apr 30, 2025

UNITED THERAPEUTICS Corp SEC 10-Q Report - TradingView

Apr 30, 2025

Apr 29, 2025

United Therapeutics Sells Priority Review Voucher to AbbVie - CHEManager

Apr 29, 2025

Apr 29, 2025

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail

Apr 29, 2025

Apr 28, 2025

United Therapeutics secures $2.5 billion credit facility - Investing.com

Apr 28, 2025

Apr 28, 2025

United Therapeutics Enters Credit Agreement With Wells FargoSEC Filing - marketscreener.com

Apr 28, 2025

Apr 28, 2025

United Therapeutics secures $2.5 billion credit facility By Investing.com - Investing.com UK

Apr 28, 2025

Apr 28, 2025

United Therapeutics Corporation Announces Credit Agreement Established for A $2.5 Billion Revolving Facility - marketscreener.com

Apr 28, 2025

Apr 26, 2025

Wells Fargo cuts United Therapeutics stock rating to Equal Weight By Investing.com - Investing.com South Africa

Apr 26, 2025

Apr 25, 2025

Wells Fargo cuts United Therapeutics stock rating to Equal Weight - Investing.com Australia

Apr 25, 2025

Apr 25, 2025

This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Benzinga

Apr 25, 2025

Apr 25, 2025

Demystifying United Therapeutics: Insights From 4 Analyst Reviews - Benzinga

Apr 25, 2025

Apr 22, 2025

Liquidia Corp files patent infringement suit against United Therapeutics By Investing.com - Investing.com Canada

Apr 22, 2025

Apr 22, 2025

Liquidia Corp files patent infringement suit against United Therapeutics - Investing.com

Apr 22, 2025

Apr 21, 2025

BofA Securities Upgrades United Therapeutics to Neutral From Underperform - marketscreener.com

Apr 21, 2025

Apr 21, 2025

United Therapeutics stock rating lifts to neutral at BofA - Investing.com

Apr 21, 2025

Apr 21, 2025

United Therapeutics stock rating lifts to neutral at BofA By Investing.com - Investing.com UK

Apr 21, 2025

Apr 21, 2025

United Therapeutics (UTHR) Stock Upgrade Amid Valuation Drop | U - GuruFocus

Apr 21, 2025

Apr 21, 2025

United Therapeutics (UTHR) Stock Upgrade Amid Valuation Drop | UTHR Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference | UTHR Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Major Phase 3 Trial Results: United Therapeutics Reveals New Lung Disease Treatment Data at ATS 2025 - Stock Titan

Apr 21, 2025

Apr 16, 2025

United Therapeutics director Raymond Dwek sells $855,480 in stock - Investing.com Australia

Apr 16, 2025

Apr 16, 2025

United Therapeutics Schedules Key Q1 2025 Financial Results: What Pharma Investors Should Watch - Stock Titan

Apr 16, 2025

Apr 16, 2025

United Therapeutics director Raymond Dwek sells $855,480 in stock By Investing.com - Investing.com India

Apr 16, 2025